Dr. Furtado explains, "Besides providing new clues for how the immune system works, this study will help us identify therapeutics that block the development of autoimmune neuropathies."
Thomas H. Brannagan, III, M.D., the Association's medical advisor affirms, "We continue to invest in critical research that builds on our understanding of neuropathy's many forms, hopeful that our investments will lead to more effective treatment and cures."
About Peripheral Neuropathy
Peripheral neuropathy is one of the most common chronic diseases in the U.S., affecting more than 20 million Americans. Neuropathy results from injury to the peripheral nerves--the motor, sensory and autonomic nerves--connecting the spinal cord to the muscles, skin, blood vessels and internal organs. It usually affects the hands and feet, causing weakness, numbness, lack of coordination or pain.
Approximately 30% of neuropathies are "idiopathic," meaning of an unknown cause; 30% are caused by diabetes. Other causes include autoimmune disorders, tumors, heredity, nutritional deficiencies, infections, trauma, and toxins.
About The Neuropathy Association
The Neuropathy Association is the leading national nonprofit organization providing neuropathy patient support and education, advocating for patients' interests, and supporting critical research. The Association has more than 50,000 members and supporters and a nationwide network of 135 patient support groups, 5 chapters, and 12 Neuropathy Centers of Excellence.
For information about peripheral neuropathy and The Neuropathy Association, visit www.neuropathy.org.
Contact Tina Tockarshewsky at (212) 692-0380
| SOURCE The Neuropathy Association Copyright©2009 PR Newswire. All rights reserved |